Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 2/20 | 0.51 |
| ▸ | CTSL | P07711 | 7/20 | 0.47 |
| ▸ | CDK1 | P06493 | 4/20 | 0.45 |
| ▸ | CDK2 | P24941 | 2/20 | 0.44 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.41 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24670404 | 0.83 | CDK2 (0.68) | PDE5ACDK1CDK2CCNA2CCNA1 | |
| SCHEMBL24668664 | 0.81 | PDE5A (0.47) | PDE5ACTSLCDK1CDK2TMIGD3 | |
| SCHEMBL24668634 | 0.80 | PDE5A (0.47) | PDE5ACTSLCDK1CDK2TMIGD3 | |
| SCHEMBL24670389 | 0.78 | CTSL (0.47) | PDE5ACTSLCDK1CDK2TMIGD3 | |
| SCHEMBL17450142 | 0.78 | CTSL (0.67) | CTSLCDK1CDK2TMIGD3ADORA2A | |
| SCHEMBL24669716 | 0.77 | CDK1 (0.48) | PDE5ACTSLCDK1CDK2TMIGD3 | |
| SCHEMBL24668665 | 0.77 | CTSL (0.46) | PDE5ACTSLCDK1CDK2TMIGD3 | |
| SCHEMBL24669107 | 0.77 | CTSL (0.47) | PDE5ACTSLCDK1CDK2TMIGD3 | |
| SCHEMBL24669727 | 0.77 | CDK1 (0.47) | PDE5ACTSLCDK1CDK2TMIGD3 | |
| SCHEMBL17450124 | 0.76 | CDK1 (0.72) | CTSLCDK1CDK2TMIGD3ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022187693-A1 | COVALENT CDK2-BINDING COMPOUNDS FOR THERAPEUTIC PURPOSES | UMBRA THERAPEUTICS INC. (US) | 2022-09-09 | — | — | WO | disclosed |